UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000062442
Receipt number R000071438
Scientific Title Effect of Intraoperative Amino Acid Administration on Postoperative Renal Function in Patients Undergoing Open Abdominal Aortic Aneurysm Repair: A Single-Center Retrospective Cohort Study
Date of disclosure of the study information 2026/08/03
Last modified on 2026/08/02 18:07:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Retrospective Observational Study of the Association Between Intraoperative Amino Acid Administration and Postoperative Renal Function in Patients Undergoing Open Abdominal Aortic Aneurysm Repair

Acronym

AAA-AA Study

Scientific Title

Effect of Intraoperative Amino Acid Administration on Postoperative Renal Function in Patients Undergoing Open Abdominal Aortic Aneurysm Repair: A Single-Center Retrospective Cohort Study

Scientific Title:Acronym

AAA-AA Study

Region

Japan


Condition

Condition

Abdominal Aortic Aneurysm

Classification by specialty

Vascular surgery Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective of this retrospective cohort study is to investigate the effect of intraoperative amino acid administration on postoperative renal function in patients undergoing open abdominal aortic aneurysm repair. The primary outcome is the change in renal function on postoperative day 1 (eGFR or Cr), and the secondary outcome is the incidence of postoperative acute kidney injury.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Change in serum creatinine concentration from the preoperative value to postoperative day 1 (Cr: serum creatinine on postoperative day 1 minus preoperative serum creatinine).

Key secondary outcomes

Incidence of postoperative acute kidney injury (AKI) according to the KDIGO criteria.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Adult patients who underwent open surgical repair for abdominal aortic aneurysm at our institution between January 2019 and December 2025.

Key exclusion criteria

1. Patients undergoing emergency surgery.
2. Patients with a preoperative serum creatinine level of 2.0 mg/dL or higher.
3. Patients receiving maintenance dialysis preoperatively.
4. Patients undergoing complex surgical procedures, such as renal artery reconstruction.

Target sample size

107


Research contact person

Name of lead principal investigator

1st name Yusuke
Middle name
Last name Minamigawa

Organization

Osaka medical and pharmaceutical university hospital

Division name

department of Anesthesiology

Zip code

5698686

Address

2-7, Daigakuchou, Takatsuki City, Osaka

TEL

0726831221

Email

yuusuke.minamigawa@ompu.ac.jp


Public contact

Name of contact person

1st name Yusuke
Middle name
Last name Minamigawa

Organization

Osaka medical and pharmaceutical university hospital

Division name

department of Anesthesiology

Zip code

5698686

Address

2-7, Daigakuchou, Takatsuki City, Osaka

TEL

0726831221

Homepage URL


Email

yuusuke.minamigawa@ompu.ac.jp


Sponsor or person

Institute

Osaka medical and pharmaceutical university

Institute

Department

Personal name



Funding Source

Organization

Osaka medical and pharmaceutical university

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka medical and pharmaceutical university

Address

2-7, Daigakuchou, Takatsuki city, Osaka

Tel

0726831221

Email

rinri@ompu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 08 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 08 Month 01 Day

Date of IRB


Anticipated trial start date

2026 Year 08 Month 01 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This is a single-center retrospective observational study of patients undergoing open abdominal aortic aneurysm repair. Data on patient characteristics, intraoperative amino acid administration and weight-adjusted amino acid dose (g/kg), aortic cross-clamp level and duration, and perioperative renal function will be collected from medical and anesthesia records. Postoperative renal function will be compared between patients who received and did not receive intraoperative amino acid administration, and the association between weight-adjusted amino acid dose and postoperative renal function will also be evaluated.


Management information

Registered date

2026 Year 08 Month 02 Day

Last modified on

2026 Year 08 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071438